These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33648578)

  • 41. [Brucellosis in the province of Almería: a retrospective study of 1988-1990].
    Vázquez Villegas J; González de Quevedo Herranz M; Pardo López-Abad J; Iranzo Luna A; Sureda Santiso MD; Andrés Carretero MA; Luján Jiménez R; Moncho Casanova P; Guijarro Penedés MI
    Aten Primaria; 1994 Jan; 13(1):31-4. PubMed ID: 8136444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spatial-temporal distribution of human brucellosis in mainland China from 2004 to 2017 and an analysis of social and environmental factors.
    Peng C; Li YJ; Huang DS; Guan P
    Environ Health Prev Med; 2020 Jan; 25(1):1. PubMed ID: 31898483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Geographical mapping and Bayesian spatial modeling of malaria incidence in Sistan and Baluchistan province, Iran.
    Zayeri F; Salehi M; Pirhosseini H
    Asian Pac J Trop Med; 2011 Dec; 4(12):985-92. PubMed ID: 22118036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors for human brucellosis in Iran: a case-control study.
    Sofian M; Aghakhani A; Velayati AA; Banifazl M; Eslamifar A; Ramezani A
    Int J Infect Dis; 2008 Mar; 12(2):157-61. PubMed ID: 17698385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human brucellosis in the People's Republic of China during 2005-2010.
    Zhong Z; Yu S; Wang X; Dong S; Xu J; Wang Y; Chen Z; Ren Z; Peng G
    Int J Infect Dis; 2013 May; 17(5):e289-92. PubMed ID: 23462301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends of human brucellosis in Central Iran (2010-2018).
    Khalilian MS; Ramazanpour J; Hosseini SM; Narrei S; Zeinalian M
    J Res Med Sci; 2021; 26():55. PubMed ID: 34729063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changing Epidemiology of Human Brucellosis, China, 1955-2014.
    Lai S; Zhou H; Xiong W; Gilbert M; Huang Z; Yu J; Yin W; Wang L; Chen Q; Li Y; Mu D; Zeng L; Ren X; Geng M; Zhang Z; Cui B; Li T; Wang D; Li Z; Wardrop NA; Tatem AJ; Yu H
    Emerg Infect Dis; 2017 Feb; 23(2):184-194. PubMed ID: 28098531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Brucellosis, a zoonotic disease present in the population: A time series study in Mexico].
    Méndez-Lozano M; Rodríguez-Reyes EJ; Sánchez-Zamorano LM
    Salud Publica Mex; 2015; 57(6):519-27. PubMed ID: 26679315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Occupational brucellosis in slaughtering of sheep and goats: study of five cases from a municipal abattoir in south-eastern Sicily].
    Rapisarda V; Valentino M; Ravalli P; Fenga C; Duscio D
    Med Lav; 2005; 96(2):134-41. PubMed ID: 16001513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Osteoarticular complications of brucellosis in Hamedan, an endemic area in the west of Iran.
    Hashemi SH; Keramat F; Ranjbar M; Mamani M; Farzam A; Jamal-Omidi S
    Int J Infect Dis; 2007 Nov; 11(6):496-500. PubMed ID: 17344084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prediction of province-level outbreaks of foot-and-mouth disease in Iran using a zero-inflated negative binomial model.
    Jafarzadeh SR; Norris M; Thurmond MC
    Prev Vet Med; 2014 Aug; 115(3-4):101-8. PubMed ID: 24768434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiologic, clinical and laboratory findings of patients with brucellosis in Hamadan, west of Iran.
    Eini P; Keramat F; Hasanzadehhoseinabadi M
    J Res Health Sci; 2012 Dec; 12(2):105-8. PubMed ID: 23241521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serological, molecular detection and potential risk factors associated with camel brucellosis in Pakistan.
    Fatima S; Khan I; Nasir A; Younus M; Saqib M; Melzer F; Neubauer H; El-Adawy H
    Trop Anim Health Prod; 2016 Dec; 48(8):1711-1718. PubMed ID: 27677292
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bayesian Spatial Survival Analysis of Duration to Cure among New Smear-Positive Pulmonary Tuberculosis (PTB) Patients in Iran, during 2011-2018.
    Nazar E; Baghishani H; Doosti H; Ghavami V; Aryan E; Nasehi M; Sharafi S; Esmaily H; Yazdani Charati J
    Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33374751
    [No Abstract]   [Full Text] [Related]  

  • 55. Preventive factors related to brucellosis among rural population using the PRECEDE model: an application of path analysis.
    Jahangiry L; Khazaee-Pool M; Mahdavi B; Ponnet K; Sarbakhsh P
    Trop Anim Health Prod; 2019 Feb; 51(2):419-428. PubMed ID: 30203266
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brucellosis update in Libya and regional prospective.
    Ahmed MO; Abouzeed YM; Bennour EM; van Velkinburgh JC
    Pathog Glob Health; 2015 Feb; 109(1):39-40. PubMed ID: 25578285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human brucellosis occurrences in inner mongolia, China: a spatio-temporal distribution and ecological niche modeling approach.
    Jia P; Joyner A
    BMC Infect Dis; 2015 Feb; 15():36. PubMed ID: 25644986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Brucellosis outbreak in Treviso province caused by infected cheese from an endemic area].
    Farina F; Fuser R; Rossi M; Scotton PG
    Infez Med; 2008 Sep; 16(3):154-7. PubMed ID: 18843213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Epidemiologic aspects of 42 cases of human brucellosis in the Republic of Djibouti].
    Gavazzi G; Prigent D; Baudet JM; Banoita S; Daoud W
    Med Trop (Mars); 1997; 57(4):365-8. PubMed ID: 9612778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigating the Incidence of Prostate Cancer in Iran 2005 -2008 using Bayesian Spatial Ecological Regression Models.
    Haddad-Khoshkar A; Jafari-Koshki T; Mahaki B
    Asian Pac J Cancer Prev; 2015; 16(14):5917-21. PubMed ID: 26320473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.